# A Study to Learn How BIIB141 (Omaveloxolone) is Processed in the Body When Taken as Capsules Compared to Sprinkled on Yogurt in Healthy Adults Aged 18 to 55

> **NCT07019064** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 52 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Omaveloxolone

## Key facts

- **NCT ID:** NCT07019064
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-11
- **Primary completion:** 2025-08-19
- **Final completion:** 2025-08-19
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07019064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07019064, "A Study to Learn How BIIB141 (Omaveloxolone) is Processed in the Body When Taken as Capsules Compared to Sprinkled on Yogurt in Healthy Adults Aged 18 to 55". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07019064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*